Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
The Washington State Tree Fruit Association says crop quality looks promising despite ongoing drought conditions.
IDA Texas’s Cooper Little discusses producer response to New World Screwworm in Texas, ongoing coordination with animal health officials, and the steps being taken to manage and protect livestock movement across the region.
The FAO report continues to serve as a key benchmark for global food market conditions, offering insight into how shifting supply and demand dynamics are impacting food systems worldwide.
Rep. Vicente Gonzalez says producers are concerned about the potential impact on cattle operations and livestock values.
Merck Animal Health shared insights on calf health at the Moly Manufacturing Beef and Greet.
Brazil Potash CEO Matt Simpson discusses global fertilizer security, the importance of domestic production, and Brazil’s push toward fertilizer independence, which could impact market competitiveness.
